Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 111151-111200 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT03264664
Study of E7386 in Participants With Selected Advanced Neoplasms
PHASE1Active, not recruiting
60 participants
Started: Jul 27, 2017 · Completed: Mar 31, 2026
1 condition1 sponsor10 locations
NCT04480242
Asthma Research in Children and Adolescents
N/AActive, not recruiting
525 participants
Started: Jul 26, 2017 · Completed: Dec 31, 2030
3 conditions1 sponsor15 locations
NCT02952508
Study of Iopofosine I 131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) and Pivotal Expansion in Waldenstrom Macroglobulinemia
PHASE2Active, not recruiting
120 participants
Started: Jul 26, 2017 · Completed: Dec 22, 2026
9 conditions1 sponsor52 locations
NCT02924857
The Chocolate Touch Study
NAActive, not recruiting
333 participants
Started: Jul 26, 2017 · Completed: Dec 31, 2026
3 conditions1 sponsor20 locations
NCT03115333
DSC-MRI in Measuring rCBV for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma
NAActive, not recruiting
146 participants
Started: Jul 25, 2017 · Completed: May 7, 2027
2 conditions2 sponsors58 locations
NCT03385109
The TransEnterix European Patient Registry
N/ARecruiting
500 participants
Started: Jul 25, 2017 · Completed: Mar 31, 2028
1 condition2 sponsors1 location
NCT03254667
LTS of Siliq vs. Other Therapies Treating of Adults With Moderate-to-Severe Psoriasis
N/AEnrolling by invitation
3,500 participants
Started: Jul 25, 2017 · Completed: Nov 30, 2031
1 condition1 sponsor1 location
NCT03127761
Assessment of Allogeneic Hematopoietic Cell Transplantation in Medicare Beneficiaries With Multiple Myeloma
N/ARecruiting
544 participants
Started: Jul 25, 2017 · Completed: Apr 30, 2028
1 condition2 sponsors1 location
NCT03400345
Human Upper Extremity Allotransplantation: F/U Protocol
N/ARecruiting
60 participants
Started: Jul 25, 2017 · Completed: Jul 30, 2036
3 conditions1 sponsor1 location
NCT03222635
Prospective Endoscopic Follow-up of Patients With Submucosal and High Risk Mucosal Esophageal Adenocarcinoma
NARecruiting
225 participants
Started: Jul 25, 2017 · Completed: Jul 25, 2028
3 conditions1 sponsor20 locations
NCT03091192
Savolitinib vs. Sunitinib in MET-driven PRCC.
PHASE3Active, not recruiting
60 participants
Started: Jul 25, 2017 · Completed: Dec 31, 2025
8 conditions2 sponsors59 locations
NCT03132454
Palbociclib and Sorafenib, Decitabine, or Dexamethasone in Treating Patients With Recurrent or Refractory Leukemia
PHASE1Active, not recruiting
32 participants
Started: Jul 25, 2017 · Completed: Dec 31, 2027
4 conditions2 sponsors1 location
NCT03251118
A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease
N/ARecruiting
15,000 participants
Started: Jul 24, 2017 · Completed: Oct 31, 2025
4 conditions1 sponsor37 locations
NCT03089034
Singapore Cohort of Patients with Advanced Heart Failure
N/AActive, not recruiting
300 participants
Started: Jul 24, 2017 · Completed: Oct 31, 2025
1 condition3 sponsors1 location
NCT04806295
The Leukemia and Lymphoma Society (LLS) National Research Registry
N/ARecruiting
1,000 participants
Started: Jul 24, 2017 · Completed: Jul 23, 2027
1 condition1 sponsor1 location
NCT03184545
Comparing the Outcome of Electrical Stimulation and Physical Therapy in Patellofemoral Pain Syndrome
PHASE3Recruiting
92 participants
Started: Jul 24, 2017 · Completed: Jun 30, 2027
1 condition1 sponsor1 location
NCT03228095
Volatiles in Breath and Headspace Analysis - Diagnostic Markers
N/AEnrolling by invitation
3,000 participants
Started: Jul 24, 2017 · Completed: Dec 31, 2025
16 conditions4 sponsors1 location
NCT03141177
A Study of Nivolumab Combined With Cabozantinib Compared to Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma
PHASE3Active, not recruiting
701 participants
Started: Jul 23, 2017 · Completed: Jan 16, 2026
1 condition3 sponsors135 locations
NCT03094143
Early Valve Replacement Guided by Biomarkers of LV Decompensation in Asymptomatic Patients With Severe AS
NAActive, not recruiting
1,000 participants
Started: Jul 21, 2017 · Completed: Jun 30, 2032
2 conditions2 sponsors1 location
NCT04014231
Novel Single Wave Assessment in Measuring Cardiac Dysfunction and Metabolic Syndrome in Patients With Cancer
N/AActive, not recruiting
160 participants
Started: Jul 21, 2017 · Completed: May 11, 2026
1 condition2 sponsors1 location
NCT03347565
Brain Function in Adolescent Eating Disorders and Healthy Peers
N/AActive, not recruiting
155 participants
Started: Jul 21, 2017 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT02791581
Understanding and Predicting Breast Cancer Events After Treatment
NAActive, not recruiting
403 participants
Started: Jul 21, 2017 · Completed: Jul 31, 2034
1 condition2 sponsors66 locations
NCT03244176
Feasibility Study of Induction and Maintenance Avelumab Plus R-CHOP in Patients With Diffuse DLBCL: The AvR-CHOP Study
EARLY_PHASE1Active, not recruiting
28 participants
Started: Jul 21, 2017 · Completed: Jul 31, 2025
1 condition2 sponsors3 locations
NCT02999022
Lithium for Fracture Treatment: a Double Blind Randomized Controlled Trial (LiFT)
PHASE2Recruiting
160 participants
Started: Jul 21, 2017 · Completed: Jun 30, 2025
1 condition2 sponsors5 locations
NCT03151629
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
N/ARecruiting
5,000 participants
Started: Jul 21, 2017 · Completed: Jan 31, 2032
1 condition1 sponsor121 locations
NCT03233399
Modulating Movement Intention Via Cortical Stimulation
NARecruiting
30 participants
Started: Jul 20, 2017 · Completed: May 31, 2027
3 conditions1 sponsor1 location
NCT03245411
Assessment of Multi-Level Interventions to Improve Adherence to Oral Medications in Cancer Patients
NARecruiting
110 participants
Started: Jul 20, 2017 · Completed: Dec 20, 2025
1 condition2 sponsors1 location
NCT03233646
Retinal Imaging in Neurodegenerative Disease
N/ARecruiting
2,000 participants
Started: Jul 20, 2017 · Completed: Dec 31, 2025
15 conditions4 sponsors1 location
NCT02541955
Use of Acthar in Rheumatoid Arthritis (RA) Related Flares
PHASE4Recruiting
40 participants
Started: Jul 20, 2017 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT02767661
Metronomic Capecitabine Plus Aromatase Inhibitor for First Line Treatment in HR(+), Her2(-) Metastatic Breast Cancer
PHASE3Active, not recruiting
240 participants
Started: Jul 19, 2017 · Completed: May 31, 2024
1 condition1 sponsor1 location
NCT03092323
A Randomized Trial of Pembrolizumab & Radiotherapy Versus Radiotherapy in High-Risk Soft Tissue Sarcoma of the Extremity
PHASE2Active, not recruiting
126 participants
Started: Jul 19, 2017 · Completed: Sep 1, 2028
1 condition3 sponsors20 locations
NCT03024489
Palbociclib With Cetuximab and IMRT for Locally Advanced Squamous Cell Carcinoma
PHASE1/PHASE2Active, not recruiting
27 participants
Started: Jul 19, 2017 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT03223922
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
NARecruiting
24 participants
Started: Jul 19, 2017 · Completed: Dec 31, 2030
1 condition1 sponsor2 locations
NCT05857618
Study to Determine if Patients Exposed to General Anesthesia Significant Numbers of Times Would Increase the Risk for Intraoperative Awareness.
N/AActive, not recruiting
1,000 participants
Started: Jul 19, 2017 · Completed: Jun 1, 2027
2 conditions1 sponsor1 location
NCT03092856
Axitinib With or Without Anti-OX40 Antibody PF-04518600 in Treating Patients With Metastatic Kidney Cancer
PHASE2Active, not recruiting
62 participants
Started: Jul 19, 2017 · Completed: Dec 31, 2026
4 conditions2 sponsors10 locations
NCT03152318
A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2
PHASE1Recruiting
62 participants
Started: Jul 18, 2017 · Completed: Jan 31, 2027
14 conditions3 sponsors5 locations
NCT03150329
Pembrolizumab and Vorinostat in Patients With Relapsed or Refractory DLBCL, FCL or HL.
PHASE1Active, not recruiting
52 participants
Started: Jul 18, 2017 · Completed: Jul 1, 2026
16 conditions2 sponsors1 location
NCT03173976
Anti-Osteoclast Therapy As Neoadjuvant in Treatment of Chondrosarcoma - Phase 1b Trial
PHASE1Active, not recruiting
17 participants
Started: Jul 18, 2017 · Completed: May 1, 2028
1 condition2 sponsors1 location
NCT03045029
ADAPT - A Patient Registry of the Real-world Use of Orenitram®
N/AActive, not recruiting
300 participants
Started: Jul 18, 2017 · Completed: Dec 31, 2025
1 condition1 sponsor41 locations
NCT03296202
Risk of Morbidity, Mortality and Long-term Monitoring of Antiretroviral Treatment in People Living With HIV
N/ARecruiting
7,200 participants
Started: Jul 18, 2017 · Completed: Jul 31, 2025
2 conditions4 sponsors24 locations
NCT03199651
Beating Lung Cancer in Ohio Protocol in Improving Survival in Patients with Stage IV Non-Small Cell Lung Cancer
NARecruiting
3,584 participants
Started: Jul 17, 2017 · Completed: Dec 31, 2028
5 conditions1 sponsor1 location
NCT03115983
LimiFlex Clinical Trial for the Treatment of Degenerative Spondylolisthesis With Spinal Stenosis
NAActive, not recruiting
299 participants
Started: Jul 17, 2017 · Completed: Jan 16, 2026
2 conditions4 sponsors28 locations
NCT03193281
KISS Study: Kinase Inhibition With Sprycel Start up
PHASE2Active, not recruiting
91 participants
Started: Jul 17, 2017 · Completed: Dec 31, 2025
1 condition2 sponsors9 locations
NCT02987387
COMPASSION XT PAS - Post-approval Study of the SAPIEN XT THV in Patients With Pulmonary Valve Dysfunction
N/AActive, not recruiting
57 participants
Started: Jul 17, 2017 · Completed: Sep 30, 2025
6 conditions1 sponsor12 locations
NCT03131908
Study of the Selective PI3K-Beta Inhibitor GSK2636771 in Combination With Pembrolizumab in Patients With Metastatic Melanoma and PTEN Loss
PHASE1/PHASE2Active, not recruiting
27 participants
Started: Jul 17, 2017 · Completed: Dec 31, 2025
2 conditions5 sponsors1 location
NCT03251027
Intensity-Modulated Stereotactic Radiation Therapy in Treating Patients With Grade II-IV Glioma
NARecruiting
125 participants
Started: Jul 17, 2017 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT04529252
Investigating the Genetic and Phenotypic Presentation of Ataxia and Nucleotide Repeat Diseases
N/ARecruiting
1,000 participants
Started: Jul 17, 2017 · Completed: Dec 31, 2026
3 conditions1 sponsor1 location
NCT04221737
Early Use of Airway Pressure Release Ventilation (APRV) in ARDS
NARecruiting
150 participants
Started: Jul 15, 2017 · Completed: Jan 31, 2026
1 condition1 sponsor1 location
NCT03153202
Study to Evaluate the Safety and Preliminary Efficacy of Ibrutinib and Pembrolizumab in Patients With Chronic Lymphocytic Leukemia (CLL) or Mantle Cell Lymphoma (MCL)
PHASE1/PHASE2Active, not recruiting
23 participants
Started: Jul 14, 2017 · Completed: Nov 30, 2026
2 conditions2 sponsors1 location
NCT04136392
The Global cVAD Study
N/AActive, not recruiting
20,000 participants
Started: Jul 14, 2017 · Completed: Jan 31, 2026
1 condition3 sponsors51 locations